Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Frédéric Sacher Added: 8 months ago
EHRA 2025 - Positive safety results of the Affera mapping and ablation system for the treatment of ventricular arrhythmias (VA) show a 6% rate of major complication.Dr Frédéric Sacher (IHU Liryc, Bordeaux, FR) joins us on-site at EHRA Congress 2025 to discuss safety results from the European Affera Ventricular Arrhythmia Ablation Registry, investigating VA ablation with the Affera Sphere-9… View more
Research Area(s) / Expertise:

Electrophysiology & Arrhythmia

Job title: Cardiologist
Dr. Joaquin Osca is a cardiologist at the La Fe University and Polytechnic Hospital in Valencia, specializing in Electrophysiology and Cardiac Arrhythmias. He was the president of the Arrhythmia Section of the Valencian Society of Cardiology until 2011, he is responsible for the Arrhythmia Unit at Vithas Hospital in Valencia and the author of many scientific publications and presentations at… View more
Author(s): Chao Jiang , Zhao Zixu Added: 2 weeks ago
AHA Scientific Sessions 2025 – Dr Chao Jiang and Dr Zhao Zixu (Beijing Anzhen Hospital, CN) discuss the findings from the DARE-AF (NCT06433479) randomized clinical trial, investigating whether dapagliflozin reduces atrial fibrillation burden following catheter ablation in patients without diabetes or heart failure.This single-center, open-label trial enrolled 200 patients with persistent atrial… View more
Author(s): Vivek Reddy Added: 3 weeks ago
AHA 2025 - Dr Vivek Y Reddy (Icahn School of Medicine at Mount Sinai, New York, US) joins us to share findings from the PFA-SHAM study (NCT05717725) investigating pulsed field ablation (PFA) versus sham ablation to treat AF. Patients enrolled in the study underwent an electrophysiology study to ensure they had no concealed AV bypass tract or supraventricular tachycardia, and patients were then… View more
Author(s): Atul Verma Added: 4 weeks ago
AHA Scientific Sessions 2025 - Dr Atul Verma (McGill University Health Centre, Montreal, CA) joins us to share outcomes from OCEAN (NCT02168829). The prospective, open-label, randomised trial aimed to investigate ongoing oral anticoagulation with rivaroxaban 15 mg daily compared to antiplatelet therapy in patients with clinical stroke risk factors at least one year post-successful catheter… View more
Job title: Electrophysiologist
Dr Nicoletta Ventrella is an MD-trained electrophysiologist at Institute for Clinical and Experimental Medicine (IKEM) in Prague, Czechia. She serves as an Electrophysiology Fellow in the Department of Cardiology. Her work focuses on cardiac arrhythmias, cardiac electrophysiology and echocardiography. She has authored multiple peer-reviewed publications, including on pulsed-field ablation and… View more
Author(s): Luigi Di Biase Added: 8 months ago
EHRA 2025 - In this highlights video, Arrhythmia Academy Editor-in-Chief, Dr Luigi Di Biase (Montefiore Health System, New York City, US) provides a concise and insightful summary of the late-breaking trials presented at the conference that he believes will change his practice.Trials covered in detail include:High Power Short Duration Ablation Vs CryoablationCryoablation Vs PFAVOLT CE MarkDual… View more
Job title: Director of Electrophysiology Laboratory
Research Expertise Electrophysiology of the human atria and ventricles Mechanism of supraventricular and ventricular arrhythmias Anatomic and electrophysiologic substrate of atrial and ventricular arrhythmias. Catheter ablative therapy in atrial and ventricular arrhythmias Device therapy in management of ventricular arrhythmias Arrhythmogenic cardiomyopathy and cardiac arrhythmias … View more
Author(s): Vivek Reddy Added: 7 months ago
HRS 25 - 12 month outcomes of the Globe Pulsed Field Ablation System in patients with paroxysmal atrial fibrillation (PAF) suggest the device is safe and effective.We are joined by Dr Vivek Reddy (Mount Sinai Hospital, New York, US) to discuss the findings from the PULSAR IDE trial, a global, prospective, multicenter, single-arm study designed to asses the safety and long-term efficacy of the… View more
Research Area(s) / Expertise:
Prof. Dr. Katja Zeppenfeld, MD, PhD, FESC, FEHRA is a board-certified internist, cardiologist, full professor in cardiac electrophysiology and head of the clinical electrophysiology unit of the Heart Center Leiden. Prof Zeppenfeld's clinical interests include diagnosis and treatment of complex cardiac arrhythmias with a particular focus on catheter ablation of ventricular tachycardia and… View more